Advisory: Alert on Adverum Biotechnologies from press release by law firm withdrawn
08/04/2025 15:27
An alert on Adverum Biotechnologies ADVM.O was inadvertently published from a press release by a law firm and has been withdrawn. There will not be any substitute. STORY_NUMBER: nFWN3QM1IA STORY_DATE: 08/04/2025 STORY_TIME: 02:02:21 GMT ((bangalore.newsroom@thomsonreuters.com))
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)